American Health Regulator Usfda Has Pulled Up Lantech Pharmaceuticals For Violation Of Current Good Manufacturing Practice Norms, Including Failure To Investigate Presence Of A Carcinogen In A Solvent, At Its Andhra Pradesh-Based Manufacturing Plant.
Found this useful? Share it with your team.
